CRH Medical Corp (TSE:CRH) rose 10.4% on Monday . The stock traded as high as C$2.98 and last traded at C$2.96. Approximately 490,190 shares changed hands during mid-day trading, an increase of 0% from the average daily volume of 488,203 shares. The stock had previously closed at C$2.68.
CRH has been the subject of several recent analyst reports. Royal Bank Of Canada lowered their target price on shares of CRH Medical Corp from C$8.50 to C$6.00 and set an “outperform” rating for the company in a research note on Friday, July 21st. Scotiabank downgraded shares of CRH Medical Corp from an “outperform” rating to a “sector perform” rating and lowered their target price for the company from C$10.00 to C$8.00 in a research note on Friday, July 14th. TD Securities lowered their target price on shares of CRH Medical Corp from C$10.50 to C$10.00 and set a “buy” rating for the company in a research note on Friday, July 14th. National Bank Financial lowered their target price on shares of CRH Medical Corp from C$9.00 to C$7.00 in a research note on Monday, July 17th. Finally, Bloom Burton downgraded shares of CRH Medical Corp from a “buy” rating to an “accumulate” rating in a research note on Friday, July 14th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. CRH Medical Corp presently has a consensus rating of “Buy” and an average price target of C$6.75.
The stock has a market capitalization of $217.86 million and a P/E ratio of 30.00. The firm’s 50 day moving average is $3.36 and its 200 day moving average is $7.49.
In related news, Director David Johnson sold 30,000 shares of the stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of C$5.67, for a total value of C$170,100.00.
CRH Medical Corp Company Profile
CRH Medical Corporation provides products and services to physicians for the treatment of gastrointestinal diseases in the United States. It offers anesthesia services for patients undergoing endoscopic procedures; and CRH ORegan System, a single use, disposable, and hemorrhoid banding technology for treating hemorrhoid grades IIV.
Receive News & Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related companies with MarketBeat.com's FREE daily email newsletter.